CCRM

CCRM is a Canadian organisation dedicated to accelerating the commercialisation of regenerative medicine-based technologies and cell and gene therapies.

Established to bridge the gap between scientific innovation and marketable therapies, CCRM serves as a catalyst in the regenerative medicine sector. By collaborating with academic institutions, industry partners, and investors, CCRM facilitates the translation of laboratory discoveries into viable clinical applications. Their comprehensive approach encompasses technology development, venture investment, and advanced manufacturing solutions, all aimed at overcoming the challenges inherent in bringing regenerative treatments to patients.

Key Products and Services

• CGT Manufacturing: CCRM offers expertise in cell and gene therapy (CGT) manufacturing, providing specialised infrastructure and collaborative processes to support the production of advanced therapies.
• Technology Development: Through initiatives like the Incubation Program and Venture by Design, CCRM supports the development and commercialisation of innovative technologies in the regenerative medicine field.
• Venture Investment: CCRM engages in strategic investments, offering funding and support to emerging companies within the regenerative medicine landscape.

By leveraging its extensive network and resources, CCRM is at the forefront of transforming regenerative medicine research into tangible health solutions. Their commitment to overcoming commercialisation bottlenecks ensures that pioneering therapies can reach patients more efficiently, ultimately contributing to improved global health outcomes.